Attachment 03. IRB Approval Letter

May 23, 2023

Cecilia Teal
Director, Research
EurekaFacts, LLC
51 Monroe, PE-02
Rockville, MD 20850
RE: CDC – Folic Acid study (IRB No. 63)
Dear Ms. Teal,
This will confirm that the EurekaFacts, LLC Ins�tu�onal Review Board (FW#25452) met on 5/19/2023 to
review the above cap�oned research project’s review memo and Proposal Statement of Work (SOW).
Assis�ng me with this review were Neva Gavakian and Jorge Restrepo.
The IRB members present and vo�ng unanimously approved this project, with no reserva�ons or
concerns expressed. Please note that you are required to no�fy IRB immediately if you make changes to
the protocol that affect the par�cipants.
This ini�al approval is effec�ve for 12 months from the date the IRB met and approved the project, a�er
which your project must again be presented to the IRB for an annual review.

Bohdana Sherehiy, PhD
Chair,
Ins�tu�onal Review Board
EurekaFacts, LLC
(202) 794-8915